168 related articles for article (PubMed ID: 27682513)
21. Immunological Biomarkers in Postinfectious Irritable Bowel Syndrome.
Pike BL; Paden KA; Alcala AN; Jaep KM; Gormley RP; Maue AC; Christmann BS; Elson CO; Riddle MS; Porter CK
J Travel Med; 2015; 22(4):242-50. PubMed ID: 26058758
[TBL] [Abstract][Full Text] [Related]
22. Local and Long-Distance Calling: Conversations between the Gut Microbiota and Intra- and Extra-Gastrointestinal Tract Infections.
Denny JE; Powell WL; Schmidt NW
Front Cell Infect Microbiol; 2016; 6():41. PubMed ID: 27148490
[TBL] [Abstract][Full Text] [Related]
23. Effects of bacteria on the enteric nervous system: implications for the irritable bowel syndrome.
Wood JD
J Clin Gastroenterol; 2007; 41 Suppl 1():S7-19. PubMed ID: 17438418
[TBL] [Abstract][Full Text] [Related]
24. The small intestinal bacterial overgrowth. Irritable bowel syndrome hypothesis: implications for treatment.
Vanner S
Gut; 2008 Sep; 57(9):1315-21. PubMed ID: 18250127
[No Abstract] [Full Text] [Related]
25. Study of small intestinal bacterial overgrowth in North Indian patients with irritable bowel syndrome: a case control study.
Rana SV; Sinha SK; Sikander A; Bhasin DK; Singh K
Trop Gastroenterol; 2008; 29(1):23-5. PubMed ID: 18564663
[TBL] [Abstract][Full Text] [Related]
26. Probiotics in Irritable Bowel Syndrome: The Science and the Evidence.
Quigley EM
J Clin Gastroenterol; 2015; 49 Suppl 1():S60-4. PubMed ID: 26447967
[TBL] [Abstract][Full Text] [Related]
27. The use of probiotics in IBD and IBS.
De Greef E; Vandenplas Y; Hauser B; Devreker T; Veereman G
Minerva Pediatr; 2014 Oct; 66(5):491-500. PubMed ID: 25243502
[TBL] [Abstract][Full Text] [Related]
28. Hydrogen glucose breath test to detect small intestinal bacterial overgrowth: a prevalence case-control study in irritable bowel syndrome.
Lupascu A; Gabrielli M; Lauritano EC; Scarpellini E; Santoliquido A; Cammarota G; Flore R; Tondi P; Pola P; Gasbarrini G; Gasbarrini A
Aliment Pharmacol Ther; 2005 Dec; 22(11-12):1157-60. PubMed ID: 16305730
[TBL] [Abstract][Full Text] [Related]
29. Gut microbiota role in irritable bowel syndrome: New therapeutic strategies.
Distrutti E; Monaldi L; Ricci P; Fiorucci S
World J Gastroenterol; 2016 Feb; 22(7):2219-41. PubMed ID: 26900286
[TBL] [Abstract][Full Text] [Related]
30. Abnormal breath tests to lactose, fructose and sorbitol in irritable bowel syndrome may be explained by small intestinal bacterial overgrowth.
Nucera G; Gabrielli M; Lupascu A; Lauritano EC; Santoliquido A; Cremonini F; Cammarota G; Tondi P; Pola P; Gasbarrini G; Gasbarrini A
Aliment Pharmacol Ther; 2005 Jun; 21(11):1391-5. PubMed ID: 15932370
[TBL] [Abstract][Full Text] [Related]
31. Lactulose breath testing and irritable bowel syndrome.
Grover M; Whitehead WE
Am J Gastroenterol; 2008 Oct; 103(10):2652-3; author reply 2653-4. PubMed ID: 18855858
[No Abstract] [Full Text] [Related]
32. Comparison of lactulose and glucose breath test for diagnosis of small intestinal bacterial overgrowth in patients with irritable bowel syndrome.
Rana SV; Sharma S; Kaur J; Sinha SK; Singh K
Digestion; 2012; 85(3):243-7. PubMed ID: 22472730
[TBL] [Abstract][Full Text] [Related]
33. [Post-infectious irritable bowel syndrome].
Serghini M; Karoui S; Boubaker J; Filali A
Tunis Med; 2012 Mar; 90(3):205-13. PubMed ID: 22481191
[TBL] [Abstract][Full Text] [Related]
34. The putative role of the intestinal microbiota in the irritable bowel syndrome.
Collins SM; Denou E; Verdu EF; Bercik P
Dig Liver Dis; 2009 Dec; 41(12):850-3. PubMed ID: 19740713
[TBL] [Abstract][Full Text] [Related]
35. [Tests to detect GI motility disorders and GI sensation in irritable bowel syndrome].
Okumura T
Nihon Rinsho; 2006 Aug; 64(8):1457-60. PubMed ID: 16898612
[TBL] [Abstract][Full Text] [Related]
36. Heptose 1,7-Bisphosphate Directed TIFA Oligomerization: A Novel PAMP-Recognizing Signaling Platform in the Control of Bacterial Infections.
Pachathundikandi K; Backert S
Gastroenterology; 2018 Mar; 154(4):778-783. PubMed ID: 29337150
[No Abstract] [Full Text] [Related]
37. Gut microbiota as potential orchestrators of irritable bowel syndrome.
Bennet SM; Ohman L; Simren M
Gut Liver; 2015 May; 9(3):318-31. PubMed ID: 25918261
[TBL] [Abstract][Full Text] [Related]
38. Treating irritable bowel syndrome with probiotics: the evidence.
Parkes GC; Sanderson JD; Whelan K
Proc Nutr Soc; 2010 May; 69(2):187-94. PubMed ID: 20236566
[TBL] [Abstract][Full Text] [Related]
39. [Psychoneuroimmunology in irritable bowel syndrome].
Sebastián Domingo JJ; Sebastián Sánchez B
Gastroenterol Hepatol; 2015; 38(7):413-6. PubMed ID: 25767001
[No Abstract] [Full Text] [Related]
40. Is diarrhea-predominant irritable bowel syndrome a low-grade gut inflammatory disorder?
Ghoshal UC
Trop Gastroenterol; 2012; 33(4):239-41. PubMed ID: 23923348
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
